Texas AG Ken Paxton defends HB 20 at the Supreme Court, a law preventing social media platforms from censoring based on viewpoint, amidst a wider debate on online speech regulation and the First Amendment.

The University of Texas at Austin has achieved over $1 billion in research expenditures, marking a 25% increase and signaling its global research prominence.

The Odysseus lander, created by Intuitive Machines, has successfully landed near the lunar south pole, signaling a step towards a lunar economy with benefits for Central Texas's aerospace sector.

A report suggests that investment in regulatory technology (RegTech) may lead to lower customer complaints and fewer regulatory issues, despite higher costs, particularly benefiting larger firms.

UT Austin scientists discover a potential new therapy target, SLC25A51, to slow growth in acute myeloid leukemia without harming healthy cells, paving the way for future treatments.

Studies uncover high levels of nanoplastics in popular bottled water brands, with uncertain health impacts; researchers explore hydrogel-based filtration to tackle the problem.

Allen J. Bard, known as the "father of modern electrochemistry," has died at 90. His pioneering work and mentorship at The University of Texas at Austin left a lasting legacy.

The Texas Workforce Commission celebrates CTE month, highlighting the role of technical education in job training and career readiness, and promotes programs like Dual Credit and JET.

Bill Nye will speak at the Long Center in Austin on February 21, coinciding with the GARSEF, to promote science engagement and the Long Reach for The Arts initiative.

Meta will start labeling AI-generated images on its platforms to alert users to their synthetic origin, with plans to extend standards to video and audio.

The Texas DPS has launched a Violent Offender Database to inform the public about individuals convicted of severe violent crimes, aiming to enhance community safety.

The Austin Planning Commission voted to recommend amendments to the city's telework policy, amid a debate on making remote work permanent for city employees.

Researchers discover FEM-1689, a potential non-opioid treatment for chronic pain targeting a protein linked to neuropathic pain, with promising effects observed in animal models.